SurvOm is an advanced cloud-based bioinformatics platform tailored for multi-omics data analysis, designed to meet the evolving needs of researchers and clinicians in understanding complex disease mechanisms. By integrating genomics, proteomics, transcriptomics, and other omics data, SurvOm empowers users to gain comprehensive, actionable insights crucial for translational and clinical research. The platform leverages cutting-edge AI and machine learning to streamline target discovery, biomarker identification, and patient cohort segmentation—key areas supporting personalized medicine, early disease detection, and innovative drug development. SurvOm’s capabilities enable users to pinpoint therapeutic targets and biomarkers with precision, facilitating the identification of disease-related patterns and fostering advancements in targeted therapies. Recognizing the diverse needs of its users, SurvOm offers fully customizable analytical pipelines that adapt to specific project requirements. Its data curation services ensure high-quality, harmonized datasets by organizing and processing data according to rigorous standards, making the information readily usable for in-depth analyses. Additionally, SurvOm’s interactive visualization tools enhance user experience by providing intuitive, detailed data representation, allowing researchers to explore and interpret results seamlessly. Designed to serve academia, pharmaceutical companies, and biotech organizations, SurvOm is more than just a software platform—it’s a comprehensive solution that supports precision medicine and transformative research. Whether for academic studies or pharmaceutical innovation, SurvOm is positioned to play a pivotal role in the future of multi-omics research.
Private Limited Company
Art
Prototype
NA
Year of Establishment: 2021